Skip to main content
VCbacked
Log inGet Started

Fusion Pharmaceuticals

Hamilton, Canada

Fusion Pharmaceuticals is a clinical-stage oncology company focused on developing radiopharmaceuticals.

$60.0M raised
Feb 2023
Post-IPO Equity
BiopharmaBiotechnologyMedicalOncologyPharmaceutical

Top Investors

Perceptive AdvisorsAdams Street PartnersOrbiMedRock Springs CapitalJohnson & Johnson Innovation

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Fusion Pharmaceuticals

How much funding has Fusion Pharmaceuticals raised?
Fusion Pharmaceuticals has raised $60.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in February 2023.
Who are Fusion Pharmaceuticals's investors?
Fusion Pharmaceuticals's investors include Perceptive Advisors, Adams Street Partners, OrbiMed, Rock Springs Capital, Johnson & Johnson Innovation.
Where is Fusion Pharmaceuticals headquartered?
Fusion Pharmaceuticals is headquartered in Hamilton, Canada.
What does Fusion Pharmaceuticals do?
Fusion Pharmaceuticals is a clinical-stage oncology company focused on developing radiopharmaceuticals.
What stage is Fusion Pharmaceuticals at?
Fusion Pharmaceuticals is at the Post-IPO Equity stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Fusion Pharmaceuticals — Funding & Investors." VCBacked, February 13, 2023, https://www.vcbacked.co/company/fusion-pharmaceuticals. Accessed July 2, 2026.
APA
VCBacked. (2023). Fusion Pharmaceuticals — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/fusion-pharmaceuticals
Wikipedia (cite web)
{{cite web |title=Fusion Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/fusion-pharmaceuticals |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biopharma

View all
Allterum Therapeutics
Houston$1.0M
Epsilogen
London$16.3M
Cairn Therapeutics
Tucson$3.0M
Living In Silico Inc.
Brampton$3K
KuriBio
Berkeley$150K
Systemic Bio
Houston$15.0M